Skip to main content
SpringerLink
Log in

Pharmacological Management of Neuropathic Pain

  • Chapter
  • First Online:
Advances in Chronic and Neuropathic Pain

Part of the book series: Contemporary Rheumatology ((CR))

  • 722 Accesses

Abstract

Neuropathic pain is defined as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system”.

Prevalence of pain with predominantly neuropathic origin or pain with neuropathic characteristics is estimated to be 7 to 8% in general population.

Neuropathic pain poses a significant burden on patients, society, and healthcare systems.

Varied presentations and difficulty in diagnosis and treatment make it a very debilitating condition.

Neuropathic pain differs from nociceptive pain and therefore therapeutic management of neuropathic pain differs from nociceptive pain.

In this chapter we will be learning about the definition, diagnosis and evidence based treatment modalities for neuropathic pain management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.

    Article  CAS  PubMed  Google Scholar 

  2. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7.

    Article  PubMed  Google Scholar 

  3. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281–9.

    Article  PubMed  Google Scholar 

  4. Alleman CJ, Westerhout KY, Hansen M, et al. Humanistic and eco–nomic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Diabetes Res Clin Pract. 2015;109:215–25.

    Article  PubMed  Google Scholar 

  5. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–19.

    Article  PubMed  Google Scholar 

  6. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:2–15.

    Article  Google Scholar 

  8. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938.

    PubMed  Google Scholar 

  9. Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1:CD007076.

    PubMed  Google Scholar 

  10. National Institute of Clinical Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings, https://www.nice.org.uk/guidance/cg173

  11. Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede R-D. Neuropathic low back pain in clinical practice. Eur J Pain. 2016;20:861e3.

    Article  Google Scholar 

  12. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001;25:871–80.

    Article  CAS  PubMed  Google Scholar 

  13. Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J Neurosci. 2006;26:11501–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wiech K, Ploner M, Tracey I. Neurocognitive aspects of pain perception. Trends Cogn Sci. 2008;12:306–13.

    Article  PubMed  Google Scholar 

  15. Knadler MP, Lobo E, Chappell J, et al. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011;50(5):281–94.

    Article  CAS  PubMed  Google Scholar 

  16. Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain. Pain. 2015;156:S104–14.

    Article  PubMed  Google Scholar 

  17. Bauer CS, Rahman W, Tran-Van-Minh A, et al. The anti-allodynic α2δ ligand pregabalin inhibits the trafficking of the calcium channel α2δ-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans. 2010;38:525–8.

    Article  CAS  PubMed  Google Scholar 

  18. Zhou C, Luo ZD. Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha-2-delta-1 subunit protein. Eur J Pain. 2014;18:649–58.

    Article  CAS  PubMed  Google Scholar 

  19. Suto T, Severino AL, Eisenach JC, et al. Gabapentin increases extracellular glutamatergic level in the locus coeruleus via astroglial glutamate transporter-dependent mechanisms. Neuropharmacology. 2014;81:95–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Simpson DM, Brown S, Tobias J. NGX-4010 C107 study group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology. 2008;70:2305–13.

    Article  CAS  PubMed  Google Scholar 

  21. Backonja MM, Malan TP, Vanhove GF, Tobias JK. C102/106 study group. NGX4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med. 2010;11:600–8.

    Article  PubMed  Google Scholar 

  22. Hans GH, Robert DN, Van Maldeghem KN. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report. Spinal Cord. 2008;46:311–3.

    Article  CAS  PubMed  Google Scholar 

  23. Attal N, Gaudé V, Brasseur L, et al. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000;54:564–74.

    Article  CAS  PubMed  Google Scholar 

  24. Wallace MS, Laitin S, Licht D, Yaksh TL. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology. 1997;86:1262–72.

    Article  CAS  PubMed  Google Scholar 

  25. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327–60. https://doi.org/10.2165/00003088-200342040-00003.

    Article  CAS  PubMed  Google Scholar 

  26. Labianca R, Sarzi-Puttini P, Zuccaro SM, et al. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin Drug Investig. 2012;32(Suppl 1):53–63. https://doi.org/10.2165/11630080-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  27. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7:R1046–51. https://doi.org/10.1186/ar1782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;CD006605

    Google Scholar 

  29. Childers WE, Baudy RB. N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief. J Med Chem. 2007;50:2557–62.

    Article  CAS  PubMed  Google Scholar 

  30. Webster LR, Walker MJ. Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain. Am J Ther. 2006;13(4):300–5.

    Article  PubMed  Google Scholar 

  31. Pud D, Eisenberg E, Spitzer A, et al. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain. 1998;75(2–3):349–54.

    Article  CAS  PubMed  Google Scholar 

  32. Raffa RB, Burdge G, Gambrah J, et al. Cebranopadol: novel dual opioid/NOP receptor agonist analgesic. J Clin Pharmacol Ther. 2017;42:8e17.

    Article  Google Scholar 

  33. Smith MT, Anand P, Rice AS. Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies. Pain. 2016;157:S33e41.

    Article  Google Scholar 

  34. Moisset X, Bouhassira D, Couturier JA, Alchaar H, Conradi S, Delmotte MH, Lanteri-Minet M, Lefaucheur JP, Mick G, Piano V, Pickering G, Piquet E, Regis C, Salvat E, Attal N. Pharmacological and non-pharmalogical treatments for neuropathic pain: systemic review and French recommendations. Rev Neurol. 2020;176(5):325–52. https://www.sciencedirect.com/science/article/pii/S0035378720304720

    Article  CAS  PubMed  Google Scholar 

  35. Moisset X, Bouhassira D, Couturier JA, Alchaar H, Conradi S, Delmotte MH, Lanteri-Minet M, Lefaucheur JP, Mick G, Piano V, Pickering G, Piquet E, Regis C, Salvat E, Attal N. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol. 2020;176:325–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Consultant in Pain Medicine, Ashford & St Peter’s NHS Foundation Trust, London, UK

    Kunal Targe

  2. Consultant in Pain Medicine, Clevecland Clinic Abu Dhabi, Abu Dhabi, UAE

    Sadiq Bhayani

Authors
  1. Kunal Targe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sadiq Bhayani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. SMARTMD Philippines, Centuria Medical MakatiMakati City, Philippines

    Jeimylo de Castro

  2. Institute Medical Sciences, Canterbury Christ Church University, Canterbury, Kent, UK

    Yasser El Miedany

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Targe, K., Bhayani, S. (2022). Pharmacological Management of Neuropathic Pain. In: de Castro, J., El Miedany, Y. (eds) Advances in Chronic and Neuropathic Pain. Contemporary Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-10687-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-10687-3_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-10686-6

  • Online ISBN: 978-3-031-10687-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation